Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2025 Jul 17;6(10):100880. doi: 10.1016/j.jtocrr.2025.100880

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2025 The Authors

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Impact of ICB monotherapy on (A) overall survival and (B) progression-free survival in LUAD subgroups. Top Panels: Kaplan-Meier estimates survival outcomes between patients who received ICB monotherapy (Yes, orange) or PD alone (No, teal). Bottom Panels: Forest plot of multivariable Cox regression analysis within LUAD subgroups. Left top and bottom panels: KRAS mutation (KRAS^MUT), Right top panel: KRAS-wild-type (KRAS^WT). ICB, immune checkpoint blockade; LUAD, lung adenocarcinomas; PD, platinum-doublet treatment.